Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs Dexamethasone Implant in BRVO-ME
NCT03892434Phase 4Unknown
- Sponsor
- Yeungnam University College of Medicine
- Start
- Mar 2019
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexamethasone in macular edema (2 arms), sponsored by Yeungnam University College of Medicine. Primary endpoint: Mean change of best corrected visual acuity at 24 weeks. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
macular edema
Beyond the preview
Go deeper on NCT03892434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03892434.